White Winston Select Asset Fund Series Fund MP-18, LLC - 29 Mar 2022 Form 4 Insider Report for MusclePharm Corp

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 29 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Mar 2022, 19:19:00 UTC
Source filing: View source filing
Reporting owner signature: White Winston Select Asset Fund Series Fund MP-18, By: White Winston Select Asset Funds, LLC, its Manager, By: /s/ Todd M. Enright, Manager

Key filing fact

White Winston Select Asset Fund Series Fund MP-18, LLC filed Form 4 for MusclePharm Corp on 31 Mar 2022.

Key facts

This page summarizes White Winston Select Asset Fund Series Fund MP-18, LLC's Form 4 filing for MusclePharm Corp.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 Mar 2022, 19:19.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MSLP transaction

Common Stock

Sale

Transaction value: $0
Shares: -626,826
Change %: -17%
Price: $0.000000
Shares after: 3,021,529
Date: 29 Mar 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On March 29, 2022 (the "Transaction Date"), the Reporting Persons transferred 626,826 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), in an off-market transaction (the "Transaction").

Footnote F2

For purposes of the Transaction, the value of the transferred shares of Common Stock was deemed to be $0.39 per share, the last reported sale price of the Issuer's Common Stock on the Transaction Date.